Ultragenyx Pharmaceutical Inc
RARE
NASDAQ
Biotechnology
$26.49
USD
+0.11 (+0.42%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $2.60B
Volume 1.2M
Price Target
$35.00 – $96.00
USD
The 3 analysts offering 1-year price forecasts have a max estimate of $96.00 and a min estimate of $35.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$60.33
+$11.5 vs prior
Implied Upside
+127.8%
+43.5% vs prior
Analyst Covering
3
-7 vs prior period
Consensus
Buy
Improved vs prior
Signal Quality
Consensus Freshness
23%
Many ratings are older - consensus may be less current
Analyst Agreement
Low
Targets are widely dispersed - limited agreement on price
Mean vs Median
$10 Gap
Median $50.00 vs avg $60.33 - a few bullish outliers are pulling the average up
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
3 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
3
Hold
0
Sell
0
Strong Sell
0
3 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Raghuram Selvaraju | HC Wainwright & Co. | Buy | Reiterated | 5 days ago | Plus | Plus | Plus |
Debjit Chattopadhyay | Guggenheim | Buy | Maintained | 1 week ago | Plus | Plus | Plus |
Kristen Kluska | Cantor Fitzgerald | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
BEAM
Beam Therapeutics Inc
$26.75
▲ +0.9%
GRAL
Grail Inc
$67.87
▼ -0.5%
NRIX
Nurix Therapeutics Inc
$27.05
▼ -0.5%
SLS
Sellas Life Sciences Group Inc
$12.78
▲ +3.4%
BCRX
BioCryst Pharmaceuticals Inc
$9.74
▼ -0.7%
CDNA
CareDx Inc
$45.32
▼ -4.3%
COAG
Hemab Therapeutics Holdings Inc
$54.94
▲ +1.8%
KOD
Kodiak Sciences Inc
$41.35
▲ +3.4%
KLRA
Kailera Therapeutics Inc
$17.94
▼ -0.2%